Home Cognetivity Neurosciences

Cognetivity Neurosciences

In operation
IPO
AI Diagnostic Platform Developer

Basic Information

Cognetivity Neurosciences is a medical technology company dedicated to developing an AI platform for the early detection of cognitive impairment, dementia, and Alzheimer's disease. Our patented rapid cognitive analysis technology aims to make early detection a reality, with the intended benefits being easier management, greater accessibility, lower cost, and enabling earlier and more accurate diagnosis.
Cognetivity Neurosciences Ltd.
London,England,United Kingdom
less than 15 people
January 01, 2013
info@cognetivity.com